CS
Samer, Caroline Flora
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Commonly used interventional procedures for non-cancer chronic spine pain : a clinical practice guideline | BMJ. British medical journal |  | 2025 | 43 | 22 | ||
| Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic Modeling | Clinical pharmacokinetics | | 2025 | 42 | 31 | ||
| The Impact of Dexamethasone and Prednisone on Apixaban and Rivaroxaban Exposure in COVID-19 Patients : A Physiologically Based Pharmacokinetic Modeling Study | Clinical pharmacology & therapeutics | | 2025 | 52 | 72 | ||
| Virtual twin approach using physiologically based pharmacokinetic modelling in hospitalized patients treated with apixaban or rivaroxaban | British journal of clinical pharmacology |  | 2025 | 43 | 0 | ||
| Consent as a compositional act - a framework that provides clarity for the retention and use of data | Philosophy, ethics, and humanities in medicine | | 2024 | 129 | 87 | ||
| Guidance on selecting optimal steady-state tacrolimus concentrations for continuous IV perfusion : insights from physiologically based pharmacokinetic modeling | Pharmaceuticals | | 2024 | 86 | 49 | ||
| Enhancing Response Rates in Web-Based Surveys: The Impact of Direct Participant Contact | Healthcare | | 2024 | 112 | 115 | ||
| Stereoselective separation of omeprazole and 5-hydroxy-omeprazole using dried plasma spots and a heart-cutting 2D-LC approach for accurate CYP2C19 phenotyping | Journal of chromatography. B | | 2024 | 95 | 95 | ||
| Antiviral Use in Mild-to-Moderate SARS-CoV-2 Infections during the Omicron Wave in Geriatric Patients | Viruses | | 2024 | 112 | 63 | ||
| Impact of a Mobile App (LoAD Calc) on the Calculation of Maximum Safe Doses of Local Anesthetics : Protocol for a Randomized Controlled Trial | JMIR research protocols | | 2024 | 128 | 49 | ||
| Local anaesthetics risks perception : a web-based survey | Heliyon | | 2024 | 61 | 28 | ||
| In vitro screening of UGT2B10 in silico prioritized putative ligands from drugs used in the pediatric hematopoietic stem cell transplantation setting | Pharmacology research & perspectives | | 2024 | 74 | 39 | ||
| CYP450 3A4/5 Containment During SARS-CoV-2 Infection | Clinical pharmacology & therapeutics | | 2023 | 57 | 64 | ||
| Practice of CYP450 genotyping and phenotyping in children in a real-life setting | Frontiers in pharmacology | | 2023 | 69 | 101 | ||
| Development and retrospective evaluation of a clinical decision support system for the efficient detection of drug-related problems by clinical pharmacists | International journal of clinical pharmacy | | 2023 | 160 | 80 | ||
| Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side | CPT: pharmacometrics & systems pharmacology | | 2023 | 137 | 141 | ||
| REPRESENT : REPresentativeness of RESearch data obtained through the 'General Informed ConsENT' | BMC medical ethics | | 2023 | 141 | 76 | ||
| Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol | Pharmaceuticals | | 2023 | 59 | 32 | ||
| Management of chronic pain associated with temporomandibular disorders : a clinical practice guideline | BMJ | | 2023 | 4 | 6 | ||
| Polygenic risk scores in pharmacogenomics : opportunities and challenges-a mini review | Frontiers in genetics | | 2023 | 88 | 43 | ||
| Case report : Hepatotoxicity and nephrotoxicity induced by methotrexate in a paediatric patient, what is the role of precision medicine in 2023 ? | Frontiers in pharmacology | | 2023 | 105 | 56 | ||
| Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study | CPT: pharmacometrics & systems pharmacology | | 2023 | 120 | 120 | ||
| Hydromorphone Prescription for Pain in Children - What Place in Clinical Practice? | Frontiers in pediatrics | | 2022 | 172 | 63 | ||
| Editorial: Precision Medicine: Impact of Cytochromes P450 and Transporters Genetic Polymorphisms, Drug-Drug Interactions, Disease on Safety and Efficacy of Drugs | Frontiers in pharmacology | | 2022 | 182 | 117 | ||
| Evaluation of CYP1A2 activity: Relationship between the endogenous urinary 6-hydroxymelatonin to melatonin ratio and paraxanthine to caffeine ratio in dried blood spots | Clinical and translational science | | 2022 | 230 | 133 | ||
| Dexamethasone exposure in normal-weight and obese hospitalized COVID-19 patients: An observational exploratory trial | Clinical and translational science | | 2022 | 141 | 87 | ||
| Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting | Journal of personalized medicine | | 2022 | 213 | 198 | ||
| Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics | CPT: pharmacometrics & systems pharmacology | | 2022 | 263 | 374 | ||
| Cyber harassment of female scientists will not be the new norm | The Lancet Infectious Diseases | | 2021 | 247 | 192 | ||
| Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva Cocktail | Clinical pharmacology and therapeutics | | 2021 | 200 | 124 | ||
| Development and Preliminary Validation of LoAD Calc, a Mobile App for Calculating the Maximum Safe Single Dose of Local Anesthetics | Healthcare | | 2021 | 186 | 77 | ||
| Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: A Systematic Review of the Literature and Analysis of VigiBase | Journal of personalized medicine | | 2021 | 209 | 107 | ||
| Case Report: Low Hematocrit Leading to Tacrolimus Toxicity | Frontiers in pharmacology | | 2021 | 230 | 121 | ||
| Drug-drug interactions with direct oral anticoagulants: practical recommendations for clinicians | The American journal of medicine | | 2021 | 158 | 0 | ||
| Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy | Clinical Pharmacology and Therapeutics | | 2021 | 228 | 2 | ||
| Mixing Drugs and Genetics: A Complex Hemorrhagic Cocktail | American Journal of Medicine | | 2021 | 277 | 5 | ||
| CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting | Frontiers in pharmacology | | 2021 | 269 | 193 | ||
| Live vaccines and immunosuppressive monoclonal antibodies: weighing up the benefit-risk assessment for natalizumab | Journal of Travel Medicine | | 2021 | 222 | 1 | ||
| Impact of computerised physician order entry (CPOE) on the incidence of chemotherapy-related medication errors: a systematic review | European journal of clinical pharmacology | | 2021 | 308 | 192 | ||
| Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature | Frontiers in pharmacology | | 2021 | 209 | 345 | ||
| Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19 | European journal of hospital pharmacy | | 2021 | 213 | 0 | ||
| Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline | BMJ | | 2021 | 234 | 2 | ||
| Impact of Inflammation on Cytochromes P450 Activity in Pediatrics: A Systematic Review | Clinical pharmacokinetics | | 2021 | 219 | 159 | ||
| Reviewing Data Integrated for PBPK Model Development to Predict Metabolic Drug-Drug Interactions: Shifting Perspectives and Emerging Trends | Frontiers in pharmacology | | 2021 | 174 | 181 | ||
| Citizens' Participation in Health and Scientific Research in Switzerland | Studies in Health Technology and Informatics | | 2020 | 481 | 115 | ||
| The Swiss Cheese Prescribing Model for Precision Medicine | American Journal of Medicine | | 2020 | 288 | 192 | ||
| Drug interactions with apixaban: A systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports | Pharmacology Research and Perspectives | | 2020 | 340 | 226 | ||
| Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs | Swiss Medical Weekly | | 2020 | 493 | 342 | ||
| Impact of acute inflammation on cytochromes P450 activity assessed by the Geneva Cocktail | Clinical Pharmacology and Therapeutics | | 2020 | 320 | 431 | ||
| Vitamin D and glaucoma: a critical review of the literature | Journal of Ophthalmology | | 2020 | 726 | 203 | ||
| Automatic Classification of Discharge Letters to Detect Adverse Drug Reactions | Studies in Health Technology and Informatics | | 2020 | 456 | 156 | ||
| Evaluation of Phenotypic and Genotypic Variations of Drug Metabolising Enzymes and Transporters in Chronic Pain Patients Facing Adverse Drug Reactions or Non-Response to Analgesics: A Retrospective Study | Journal of Personalized Medicine | | 2020 | 347 | 89 | ||
| Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail | Journal of Personalized Medicine | | 2019 | 460 | 197 | ||
| Safety issues of pharmacological acute pain treatment in children | Clinical Pharmacology and Therapeutics | | 2019 | 398 | 4 | ||
| Cytochrome P450 1A2 activity and incidence of thyroid disease and cancer after chronic or acute exposure to dioxins | Basic & Clinical Pharmacology & Toxicology | | 2019 | 461 | 4 | ||
| Preclinical Evaluation of Safety of Fucoidan Extracts From Undaria pinnatifida and Fucus vesiculosus for Use in Cancer Treatment | Integrative Cancer Therapies | | 2019 | 368 | 118 | ||
| Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling | Pediatric Research | | 2019 | 325 | 2 | ||
| The European Association for Clinical Pharmacology and Therapeutics-25 years' young and going strong | European Journal of Clinical Pharmacology | | 2019 | 328 | 279 | ||
| Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active Metabolites | Clinical Pharmacokinetics | | 2018 | 718 | 721 | ||
| Complex Drug-Drug-Gene-Disease Interactions Involving Cytochromes P450: Systematic Review of Published Case Reports and Clinical Perspectives | Clinical Pharmacokinetics | | 2018 | 509 | 707 | ||
| Prevention of potentially inappropriate medication in internal medicine patients: a prospective study using the electronic application PIM-check | Journal of Clinical Pharmacy and Therapeutics | | 2018 | 422 | 3 | ||
| When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children | Frontiers in Pharmacology | | 2018 | 542 | 288 | ||
| Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine | The Pharmacogenomics Journal | | 2018 | 651 | 236 | ||
| Severe and persistent morphine-induced respiratory depression associated with ATP-Binding Cassette Subfamily B Member 1 and catechol-O-methyltransferase genetic defects: A case report | European Journal of Anaesthesiology | | 2018 | 438 | 317 | ||
| Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients | Journal of the American Society of Nephrology | | 2017 | 565 | 3 | ||
| Cytochromes P450 activity and functionality: biomarker of drug response and valuable tool for Precision Medicine | | 2017 | 595 | 17 | |||
| Pharmacogénomique et thérapie personnalisée | Revue médicale suisse | | 2017 | 491 | 237 | ||
| Creation of the Swiss group of Pharmacogenomics and personalised Therapy (SPT) | Drug Metabolism and Personalized Therapy | | 2017 | 521 | 1 | ||
| Grundlagen und praktische Hinweise fur pharmakogenetische Tests : Personalisierte Therapie bei Psychopharmaka = Notions de base et aspects pratiques à propos de tests pharmacogénétiques : pharmacogénomique et thérapie personnalisée | InFo Neurologie und Psychiatrie | | 2017 | 402 | 2 | ||
| Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases | Journal of pharmaceutical and biomedical analysis | | 2017 | 650 | 681 | ||
| Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective study | Pharmacological research | | 2017 | 652 | 171 | ||
| "Late" Withdrawal Syndrome after Carbamazepine In Utero Exposure in a CYP2C9 Slow Metabolizer Newborn | Frontiers in Pharmacology | | 2017 | 625 | 212 | ||
| Impact d'une réconciliation médicamenteuse par un pharmacien lors de l'admission dans un service de médecine interne | Le Pharmacien Hospitalier et Clinicien | | 2017 | 282 | 215 | ||
| PIM-Check: development of an international prescription-screening checklist designed by a Delphi method for internal medicine patients | BMJ Open | | 2017 | 761 | 394 | ||
| Notions de base et aspects pratiques à propos de tests pharmacogénétiques : pharmacogénomique et thérapie personnalisée = Grundlagen und praktische Hinweise für pharmakogenetische Tests : Personalisierte Therapie bei Psychopharmaka | InFo Neurologie und Psychiatrie | | 2017 | 361 | 3 | ||
| Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation" | Circulation | | 2016 | 547 | 3 | ||
| Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect | Frontiers in pharmacology | | 2016 | 494 | 219 | ||
| Coadministration of ticagrelor and ritonavir: Toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach | Clinical pharmacology and therapeutics | | 2016 | 655 | 723 | ||
| Une histoire qui ne manque pas de mordant | Revue médicale suisse | | 2016 | 360 | 232 | ||
| HIV-Positive-to-HIV-Positive Liver Transplantation | American journal of transplantation | | 2016 | 659 | 397 | ||
| Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method | Basic & clinical pharmacology & toxicology | | 2016 | 667 | 485 | ||
| Direct oral anticoagulants: efficacy and safety in patient subgroups | Schweizerische medizinische Wochenschrift | | 2015 | 796 | 433 | ||
| Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review | New microbes and new infections | | 2015 | 605 | 1 | ||
| Corrigendum to "Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review" [New Microbes New Infect] 6 (2015) 1-4] | New microbes and new infections | | 2015 | 496 | 0 | ||
| Providing Quality Therapeutics in Switzerland: Role of the Stakeholders and Recent Incentives for Further Improvements | Clinical therapeutics | | 2015 | 701 | 6 | ||
| Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review | Current drug metabolism | | 2015 | 635 | 6 | ||
| Drug-related problems identification in general internal medicine: The impact and role of the clinical pharmacist and pharmacologist | European journal of internal medicine | | 2015 | 728 | 6 | ||
| Prediction by pharmacogenetics of safety and efficacy of non-steroidal anti- inflammatory drugs: a review | Current drug metabolism | 2014 | 648 | 0 | |||
| Geneva Cocktail for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spots | Clinical pharmacology and therapeutics | | 2014 | 909 | 387 | ||
| Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity | AIDS research and therapy | | 2014 | 719 | 926 | ||
| Prediction of Metabolic Interactions With Oxycodone via CYP2D6 and CYP3A Inhibition Using a Physiologically Based Pharmacokinetic Model | CPT: pharmacometrics & systems pharmacology | | 2014 | 652 | 258 | ||
| Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma | Bioanalysis | | 2014 | 756 | 5 | ||
| Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause? | Hepatology | | 2013 | 477 | 507 | ||
| Pharmacokinetic interaction between prasugrel and ritonavir in healthy volunteers | Basic & clinical pharmacology & toxicology | | 2013 | 648 | 408 | ||
| Clinical Course and Management of Iatrogenic Cushing's Syndrome after Co-Administration of Injected-Triamcinolone and Ritonavir: a Systematic Review | Journal of Antivirals and Antiretrovirals | | 2013 | 1,223 | 296 | ||
| Traiter efficacement la douleur incidente chez l'adulte. Donnez le bon antalgique au bon moment | Revue médicale suisse | | 2013 | 915 | 522 | ||
| Carbimazole-induced, ANCA-associated, crescentic glomerulonephritis: case report and literature review | Renal failure | | 2013 | 571 | 390 | ||
| Applications of CYP450 Testing in the Clinical Setting | Molecular diagnosis & therapy | | 2013 | 753 | 846 | ||
| Pulmonary embolism and iatrogenic Cushing's syndrome after co-administration of injected-triamcinolone and ritonavir | AIDS | | 2013 | 568 | 339 | ||
| Human urinary biomarkers of dioxin exposure: Analysis by metabolomics and biologically driven data dimensionality reduction | Toxicology letters | | 2013 | 699 | 1,132 | ||
| Serotonin syndrome following drug-drug interactions and CYP2D6 and CYP2C19 genetic polymorphisms in an HIV-infected patient | AIDS | | 2012 | 624 | 565 | ||
| Quel programme informatique de détection des interactions médicamenteuses néfastes ? | Revue médicale suisse | | 2012 | 965 | 944 | ||
| Oral flurbiprofen metabolic ratio assessment using a single-point dried blood spot | Clinical pharmacology and therapeutics | 2012 | 639 | 0 | |||
| Moving towards dose individualization of tyrosine kinase inhibitors | Cancer treatment reviews | | 2011 | 456 | 580 | ||
| Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite | Journal of pharmaceutical and biomedical analysis | | 2011 | 733 | 817 | ||
| The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone | British journal of pharmacology | | 2010 | 856 | 2 | ||
| Impact of genetic polymorphisms and drug-drug interactions on clopidogrel and prasugrel response variability | Current drug metabolism | 2010 | 659 | 0 | |||
| Réactions d'hypersensibilité immédiates aux anti-inflammatoires non stéroïdiens: allergie ou pseudo-allergie? | Revue médicale suisse | | 2010 | 672 | 1 | ||
| Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety | British journal of pharmacology | | 2010 | 633 | 1 | ||
| Pharmacogenetics of analgesics: toward the individualization of prescription | Pharmacogenomics | 2008 | 560 | 0 | |||
| Impact des cytochromes P450 2D6 et 3A sur les paramètres pharmacocinétiques et pharmacodynamiques de l'oxycodone | | 2008 | 861 | 551 | |||
| Polymorphisme génétique et interactions médicamenteuses: leur importance dans le traitement de la douleur | Canadian journal of anaesthesia | | 2005 | 541 | 397 |
